Matvælastofnun warns against consuming one batch of chicken from Reykjagarður due to suspicion of salmonella infection. The company has recalled the production batch.
The recall only applies to the following batch:
Product names: Holta, Kjörfugl and Króna chicken
Traceability number: 001-22-01-6-16. (Complete bird and chest)
Packing dates: 15.02.22 and 16.02.22
Distribution: Hagkaup stores, Krónan, KR, Nettó, and Kjörbúðin, Olís Varmahlíð
Consumers who have purchased chickens with this traceability number are asked to return the product to the relevant store, or directly to Reykjagarður hf., Fossháls 1, 110 Reykjavík
Total Adverse Events: 4 (3 Cronobacter, 1 Salmonella)
Hospitalizations: 4
Reported Deaths: 1*
Adverse Event Dates: 9/6/2021 – 12/18/2021
States with Adverse Events: MN (1), OH (1), TX (2)
Product Distribution: Nationwide and International
*One death has been reported but has not been confirmed to be solely attributable to Cronobacter infection.
If you want to check if your powdered formula is part of the recall, you can enter the product lot code on the bottom of your package on the company’s websiteExternal Link Disclaimer.
If your infant is experiencing symptoms related to Cronobacter or Salmonella infection, such as poor feeding, irritability, temperature changes, jaundice, grunting breaths, abnormal movements, lethargy, rash, or blood in the urine or stool; contact your health care provider to report their symptoms and receive immediate care.
The FDA, along with CDC and state and local partners are investigating four consumer complaints of infant illness related to products from Abbott Nutrition’s Sturgis, MI facility received from 9/20/2021 to 1/11/2022. All of the cases are reported to have consumed powdered infant formula (IF) produced from Abbott Nutrition’s Sturgis, MI facility. These complaints include three reports of Cronobacter sakazakii infections and one report of Salmonella Newport infection in infants. All four cases related to these complaints were hospitalized and Cronobacter may have contributed to a death in one case.
FDA has initiated an onsite inspection at the facility. Findings to date include several positive Cronobacter results from environmental samples taken by FDA, and adverse inspectional observations by FDA investigators. A review of the firm’s internal records also indicate environmental contamination with Cronobacter sakazakii and the firm’s destruction of product due to the presence of Cronobacter.
FDA is issuing this advisory to alert consumers to avoid purchasing or using recalled powdered infant formula produced in the Sturgis, MI facility.
On 2/17/2022, Abbott Nutrition initiated a voluntary recall of certain powdered infant formulas. Products made at the Sturgis facility can be found across the United States and were likely exported to other countries as well. Canadian health officials have also issued a recall warningExternal Link Disclaimer. FDA is continuing to investigate and will update this advisory should additional consumer safety information become available.
Recommendation
The FDA is advising consumers not to use recalled Similac, Alimentum, or EleCare powdered infant formulas. Recalled products can be identified by the 7 to 9 digit code and expiration date on the bottom of the package (see image below). Products are included in the recall if they have all three items below:
the first two digits of the code are 22 through 37 and
the code on the container contains K8, SH, or Z2, and
the expiration date is 4-1-2022 (APR 2022) or later.
Additional Information for Parents and Caregivers:
The recall does not include liquid formula products or any metabolic deficiency nutrition formulas. Consumers should continue to use all product not included in the recall.
If your regular formula is not available, contact your child’s healthcare provider for recommendations on changing feeding practices.
More information on Cronobacter and infant formula is available on CDC’s website.
Recalled powdered infant formulas have the potential to be contaminated with Cronobacter, a bacterium that can cause severe foodborne illness primarily in infants. Cronobacter infections are rare but are especially high risk for newborn infants (see symptoms below).
Cronobacter bacteria can cause severe, life-threatening infections (sepsis) or meningitis (an inflammation of the membranes that protect the brain and spine). Symptoms of sepsis and meningitis may include poor feeding, irritability, temperature changes, jaundice (yellow skin and whites of the eyes), grunting breaths, and abnormal movements. Cronobacter infection may also cause bowel damage and may spread through the blood to other parts of the body.
If your child is experiencing any of these symptoms, you should notify your child’s healthcare provider and seek medical care for your child immediately. Healthcare providers and health departments are encouraged to report any confirmed cases of Cronobactersakazakii to CDC.
Abbott is recalling specific batches of its EleCare Similac and Alimentum Similac due to the possible presence of Salmonella and Cronobacter sakazakii. No products distributed to Ireland have tested positive for the presence of Cronobacter sakazakii or Salmonella Newport. Both products are foods used for special medical purposes for infants, ordinarily to be used under medical supervision. Point-of-sale recall notices will be displayed in stores supplied with the implicated batches.
Nature Of Danger:
Salmonella and Cronobacter sakazakii can cause illness in infants if they are present in powdered infant formula. Although Cronobactersakazakii and Salmonella cannot grow in powdered infant formula, they can survive for a long period of time and therefore, pose a potential risk after rehydration if the product is temperature abused. Contamination of powdered infant formula with Cronobacter sakazakii and Salmonella can cause severe disease in infants such as diarrhoea (sometimes bloody), fever, sepsis or meningitis which can lead to serious neurological and developmental issues and can be fatal on rare occasions. Sepsis and meningitis may include poor feeding, irritability, temperature changes, jaundice (yellow skin and whites of the eyes) and abnormal breaths and movements. Among infants, those at greatest risk for infection are neonates (<28 days), particularly pre-term infants, low-birth weight infants or immunocompromised infants.
Retailers are requested to remove the implicated batches from sale and to display a point-of-sale recall notice in stores where the affected batches were sold.
Consumers:
Parents and guardians are advised not to feed the implicated batches to infants.
liver cream sold in the traditional delicatessen section of the Carrefour Market Essars store between February 8 and February 9, 2022
Brand: unbranded
Ref. Form :2022-02-0286
Version №:1
Origin of the sheet: CSF CARREFOUR-MARKET ESSARS
Legal nature of the recall: Voluntary
Identification information of the recalled product
Product category Food
Product subcategory Meats
Product brand name unbranded
Model names or references liver cream sold in the traditional delicatessen section of the Carrefour Market Essars store between February 8 and February 9, 2022
Identification of products
GTIN
Lot
1111111111111
sold between February 8 and February 9, 2022
Packaging sold by the cut, packed in food foil in a bag
Marketing start/end date From 08/02/2022 to 09/02/2022
Storage temperature Product to be stored in the refrigerator
Further information liver cream sold in the traditional delicatessen section of the Carrefour Market Essars store between February 8 and February 9, 2022
Geographic area of sale ONLY CARREFOUR MARKET ESSARS
Distributors ONLY CARREFOUR MARKET ESSARS
Practical information regarding the recall
Reason for recall suspected listeria monocytogenes
Risks incurred by the consumer Listeria monocytogenes (causative agent of listeriosis)
Enterobacter sakazakii was first described as a new bacterial species in 1980, and over a hundred scientific papers have been written about it. From 1980 to 2007 it was known as Enterobacter sakazakii, but in 2007 there was a proposal to reclassify it into a new genus Cronobacter as Cronobacter sakazakii. (1) For simplicity and for the reasons mentioned later, this discussion will continue to use the original name Enterobacter sakazakii. The proposed alternative classification is given as a section at the end and includes a discussion of the problems and the need for future studies.
Enterobacter sakazakii is a Gram-negative rod-shaped bacterium classified in the family Enterobacteriaceae. It has been isolated from three types of infection — devastating meningitis in very young babies (neonates), bacteremia (blood steam infection) in older babies, and a wide variety of infections (or colonization) in older babies, children and adults. The majority of infections reported in the peer-reviewed literature have described neonates—newborn infants, including premature infants, post-mature infants, and full-term newborns—with sepsis, meningitis, or necrotizing enterocolitis. (2) Although it has been isolated from cases of necrotizing enterocolitis, its causative role is unclear. (3)
Reported outcomes in neonatal meningitis are often severe: seizures; brain abscess; hydrocephalus; developmental delay; and death in as many as 40%–80% of cases. Premature infants are thought to be at greater risk than more mature infants, other children, or adults, and outbreaks have occurred in hospital units for newborns. (3)
Although E. sakazakii can cause illness in all age groups, infants are believed to be at greatest risk of infection and E. sakazakii was first implicated in a case of neonatal meningitis in 1958 (before the organism was given a scientific name). Since that time, around 70 cases of E. sakazakii infection have been reported, but it is likely that is the number of cases is significantly under-reported in all countries and the incidence is probably higher. (4)
The FDA says the powered formulas were linked to bacterial infections and made at a Michigan plant.
The four cases occurred in Ohio, Minnesota and Texas. However, FDA press officer Veronika Pfaeffle said the formulas made at the Sturgis facility “can be found across the United States and were likely exported to other countries as well.”
Cronobacter is a bacteria that can cause severe infections, including inflammation of the membrane surrounding the brain and spinal cord, known as meningitis. Its symptoms include poor feeding, irritability, temperature changes, jaundice, labored breathing and abnormal movements. Salmonella can cause digestive illness and fever, commonly presenting itself in the form of diarrhea, fever and abdominal cramps. Both conditions can be life-threatening for children.
Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in West Memphis, Arkansas, where an FDA inspection found insanitary conditions, including a rodent infestation, that could cause many of the products to become contaminated. The FDA is working with the company to initiate a voluntary recallExternal Link Disclaimer of the affected products.
“Families rely on stores like Family Dollar for products such as food and medicine. They deserve products that are safe,” said Associate Commissioner for Regulatory Affairs Judith McMeekin, Pharm.D. “No one should be subjected to products stored in the kind of unacceptable conditions that we found in this Family Dollar distribution facility. These conditions appear to be violations of federal law that could put families’ health at risk. We will continue to work to protect consumers.”
This alert covers FDA-regulated products purchased from Family Dollar stores in those six states from Jan. 1, 2021, through the present. Some examples of these products include human foods (including dietary supplements (vitamin, herbal and mineral supplements)), cosmetics (skincare products, baby oils, lipsticks, shampoos, baby wipes), animal foods (kibble, pet treats, wild bird seed), medical devices (feminine hygiene products, surgical masks, contact lens cleaning solutions, bandages, nasal care products) and over-the-counter (OTC) medications (pain medications, eye drops, dental products, antacids, other medications for both adults and children).
Consumers are advised not to use and to contact the company regarding impacted products. The agency is also advising that all drugs, medical devices, cosmetics and dietary supplements, regardless of packaging, be discarded. Food in non-permeable packaging (such as undamaged glass or all-metal cans) may be suitable for use if thoroughly cleaned and sanitized. Consumers should wash their hands immediately after handling any products from the affected Family Dollar stores.
Consumers who recently purchased affected products should contact a health care professional immediately if they have health concerns after using or handling impacted products. Rodent contamination may cause Salmonella and infectious diseases, which may pose the greatest risk to infants, children, pregnant women, the elderly and immunocompromised people.
Following a consumer complaint, the FDA began an investigation of the Family Dollar distribution facility in West Memphis, Arkansas, in January 2022. Family Dollar ceased distribution of products within days of the FDA inspection team’s arrival on-site and the inspection concluded on Feb. 11. Conditions observed during the inspection included live rodents, dead rodents in various states of decay, rodent feces and urine, evidence of gnawing, nesting and rodent odors throughout the facility, dead birds and bird droppings, and products stored in conditions that did not protect against contamination. More than 1,100 dead rodents were recovered from the facility following a fumigation at the facility in January 2022. Additionally, a review of the company’s internal records also indicated the collection of more than 2,300 rodents between Mar. 29 and Sep. 17, 2021, demonstrating a history of infestation.
